ISIN | LU1313772078 |
---|---|
Valor Number | |
Bloomberg Global ID | |
Fund Name | Candriam Sustainable Equity Europe I |
Fund Provider |
CANDRIAM
Serenity, Bloc - B, 19-21, route d'Arlon 8009 Strassen E-Mail: CH@Candriam.com Phone: + 352 2797-1 Web: https://www.candriam.com |
Fund Provider | CANDRIAM |
Representative in Switzerland |
CACEIS (Switzerland) SA Nyon Phone: +41 22 360 94 00 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The aim of the Sub-Fund is to enable shareholders to benefit from the growth of the European equity markets with an investment in equities selected by the portfolio management team on a discretionary basis and to outperform the benchmark. The selection is based on the stocks characteristics and growth prospects, as well as proprietary analysis of ESG criteria. |
Peculiarities |
Current Price * | 34.58 EUR | 18.09.2024 |
---|---|---|
Previous Price * | 34.73 EUR | 17.09.2024 |
52 Week High * | 35.28 EUR | 30.08.2024 |
52 Week Low * | 28.63 EUR | 27.10.2023 |
NAV * | 34.58 EUR | 18.09.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 934,298,425 | |
Unit/Share Assets *** | 206,864,876 | |
Trading Information SIX |
YTD Performance | +6.40% |
29.12.2023 - 18.09.2024
29.12.2023 18.09.2024 |
---|---|---|
YTD Performance (in CHF) | +7.78% |
29.12.2023 - 18.09.2024
29.12.2023 18.09.2024 |
1 month | +0.61% |
19.08.2024 - 18.09.2024
19.08.2024 18.09.2024 |
3 months | +0.99% |
18.06.2024 - 18.09.2024
18.06.2024 18.09.2024 |
6 months | +2.52% |
18.03.2024 - 18.09.2024
18.03.2024 18.09.2024 |
1 year | +11.08% |
18.09.2023 - 18.09.2024
18.09.2023 18.09.2024 |
2 years | +20.03% |
19.09.2022 - 18.09.2024
19.09.2022 18.09.2024 |
3 years | +4.47% |
23.09.2021 - 18.09.2024
23.09.2021 18.09.2024 |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novo Nordisk A/S Class B | 4.22% | |
---|---|---|
ASML Holding NV | 3.97% | |
KBC Groupe NV | 3.94% | |
Nestle SA | 3.91% | |
Novartis AG Registered Shares | 3.07% | |
Roche Holding AG | 2.88% | |
AstraZeneca PLC | 2.81% | |
FinecoBank SpA | 2.77% | |
Dassault Systemes SE | 2.73% | |
Unilever PLC | 2.70% | |
Last data update | 30.06.2024 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.70% |
Ongoing Charges *** | 0.85% |
SRRI ***
|
|
SRRI date *** | 31.08.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |
GMOs |